



Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PRDM16 Double Nickase Plasmid (h) | sc-403464-NIC | 20 µg | $410.00 | |||
PRDM16 Double Nickase Plasmid (h2) | sc-403464-NIC-2 | 20 µg | $410.00 |
PRDM16 encodes a PR/SET domain zinc-finger transcriptional regulator that integrates epigenetic control with lineage-specific gene expression programs. It is best known for coordinating adipocyte fate decisions, including brown and beige adipogenesis, through interactions with co-regulators and modulation of mitochondrial and oxidative metabolism gene networks. PRDM16 also contributes to developmental and stem/progenitor cell transcriptional states, influencing differentiation and tissue homeostasis. Dysregulated PRDM16 expression or rearrangement has been linked to altered metabolic phenotypes and oncogenic transcriptional programs in select hematologic contexts, making it relevant for pathway-focused mechanistic studies.
PRDM16 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the PRDM16 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within PRDM16. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt PRDM16 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of PRDM16-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.